8-bromo-2-(1-((3S,5R)-3,5-dimethylpiperazin-1-yl)butyl)-3-ethylquinazolin-4(3H)-one

ID: ALA4878042

PubChem CID: 162424450

Max Phase: Preclinical

Molecular Formula: C20H29BrN4O

Molecular Weight: 421.38

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCCC(c1nc2c(Br)cccc2c(=O)n1CC)N1C[C@@H](C)N[C@@H](C)C1

Standard InChI:  InChI=1S/C20H29BrN4O/c1-5-8-17(24-11-13(3)22-14(4)12-24)19-23-18-15(9-7-10-16(18)21)20(26)25(19)6-2/h7,9-10,13-14,17,22H,5-6,8,11-12H2,1-4H3/t13-,14+,17?

Standard InChI Key:  QIOZXBYIXUDFPK-VMZNBEPHSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   28.6663   -4.6018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6652   -5.4214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3732   -5.8303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3714   -4.1930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0800   -4.5982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0789   -5.4234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7890   -5.8347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5048   -5.4255    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.5060   -4.6003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7913   -4.1844    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.7867   -6.6519    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.2147   -4.1934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9214   -4.6037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2113   -5.8361    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2167   -3.3762    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.9330   -2.9719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9369   -2.1583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2320   -1.7441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.5215   -2.1498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5159   -2.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6301   -4.1969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3368   -4.6072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6471   -1.7541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8162   -1.7371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9202   -5.4295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3690   -3.3758    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  7 11  2  0
  9 12  1  0
 12 13  1  0
  8 14  1  0
 12 15  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 13 21  1  0
 21 22  1  0
 17 23  1  1
 19 24  1  1
 14 25  1  0
  4 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4878042

    ---

Associated Targets(Human)

CACNA2D1 Tclin Voltage-gated calcium channel alpha2/delta subunit 1 (266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.38Molecular Weight (Monoisotopic): 420.1525AlogP: 3.70#Rotatable Bonds: 5
Polar Surface Area: 50.16Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.39CX LogP: 3.85CX LogD: 1.88
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: -0.69

References

1. Fernández A, Díaz JL, García M, Rodríguez-Escrich S, Lorente A, Enrech R, Dordal A, Portillo-Salido E, Porras M, Fernández B, Reinoso RF, Vela JM, Almansa C..  (2021)  Piperazinyl Bicyclic Derivatives as Selective Ligands of the α2δ-1 Subunit of Voltage-Gated Calcium Channels.,  12  (11.0): [PMID:34795870] [10.1021/acsmedchemlett.1c00416]

Source